📰 Abl Bio News
Abl Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abl Bio. Real-time updates on events, politics, business and more.
January 12, 2022
/PRNewswire/ -- ABL Bio, Inc. (KOSDAQ: 298380), a clinical-stage biotech developing bispecific antibody technology for immuno-oncology and neurodegenerative...
January 12, 2022
/PRNewswire/ -- ABL Bio, Inc. (KOSDAQ: 298380), a clinical-stage biotech developing bispecific antibody technology for immuno-oncology and neurodegenerative...
January 12, 2022
Sanofi is the latest company to strike a deal for a Parkinson’s disease drug candidate that targets the protein alpha synuclein. The asset from ABL Bio is a bispecific antibody designed to penetrate the blood-brain barrier.